Guru Ownership Trend
Guru Analysis for Viridian Therapeutics, Inc. (VRDN)
Viridian Therapeutics, Inc. (VRDN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $39.9 M.
Top institutional holders include Ken Fisher and Steven Cohen.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $799,441.3 net outflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Ken Fisher reduced exposure by 0.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Viridian Therapeutics, Inc. (VRDN)
Major holders include Ken Fisher ($34.59 M), Steven Cohen ($6.31 M), Renaissance Technologies (RenTech) ($3.97 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 2.31 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $799,441.3, with 3 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited VRDN. The total reported sell value was $6.51 M.
Yes, 2 managers opened new positions in VRDN, and 1 increased their existing holdings. The total reported buy value was $5.71 M.